Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-18, Stock:PFE, The news for the past five days is as follows:
2019-01-11: NEWS1: NASH Space in Focus in 2019 as Firms Look to Diversify.NEWS2: Stocks Snap Win Streak as Shutdown Drags On.NEWS3: Stocks Snap Win Streak as Shutdown Drags On.NEWS4: Market Close Report: NASDAQ Composite index closes at 6,971.48 down -14.59 points.NEWS5: Market Close Report: NASDAQ Composite index closes at 6,971.48 down -14.59 points.NEWS6: 7 Pharmaceutical Stocks That Just Raised Prices This Year.NEWS7: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.NEWS8: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.NEWS9: Amarin (AMRN) Stock Up on Rumors of Acquisition by Pfizer.NEWS10: Amarin (AMRN) Stock Up on Rumors of Acquisition by Pfizer.NEWS11: For Esperion Therapeutics, 2019 Could Be a Big Year.NEWS12: For Esperion Therapeutics, 2019 Could Be a Big Year.NEWS13: Amarin (AMRN) Stock Up on Rumors of Acquisition by Pfizer.NEWS14: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.NEWS15: Health Care Sector Update for 01/11/2019: TLRY, ADXS, APHA, JNJ, PFE, ABT, MRK, AMGN.NEWS16: Health Care Sector Update for 01/11/2019: TLRY, ADXS, APHA, JNJ, PFE, ABT, MRK, AMGN.NEWS17: Pfizer and the Urge to Merge.NEWS18: For Esperion Therapeutics, 2019 Could Be a Big Year.NEWS19: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for January 14, 2019.NEWS20: Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for January 14, 2019.NEWS21: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 14, 2019.NEWS22: AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 14, 2019.NEWS23: 4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019.NEWS24: 4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019.NEWS25: This Market May Just Be in an Uptrend: Market Recon.NEWS26: 4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019.NEWS27: For Strong Returns, Try Stock in Top Spenders on R&D.NEWS28: Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 1/11/2019.NEWS29: Validea James P. O'Shaughnessy Strategy Daily Upgrade Report - 1/11/2019.
2019-01-14: NEWS1: Democrats target drug prices.NEWS2: Pharma Stocks Topple After House Dems Launch Drug-Pricing Probe.NEWS3: Stocks slip as corporate earnings season begins.NEWS4: This Biotech Stock Plunged On Its Looming Rivalry With Pfizer.NEWS5: What Caused Exact Sciences Shares to Fall 19.1% in December.NEWS6: What Caused Exact Sciences Shares to Fall 19.1% in December.NEWS7: House Dems announce sweeping investigation of drug pricing.NEWS8: House Dems announce sweeping investigation of drug pricing.NEWS9: House Democrats launch drug-pricing probe into a dozen major health-care companies.NEWS10: House Democrats launch drug-pricing probe into a dozen major health-care companies.NEWS11: House Democrats launch drug pricing probe into a dozen major health-care companies.NEWS12: Sell Amarin Stock on the Recent Takeover Rumors Rally.NEWS13: Why Dow Jones' Pfizer Is Prepped To Rival These 2 Biotech Stocks.NEWS14: How To Approach Q4 Earnings: The Global Perspective.NEWS15: Modern Value Investing: Adding to the Value Investing Toolbox.NEWS16: Pfizer's new drug applications for tafamidis accepted for filing by FDA.NEWS17: Pfizer&apos;s new drug applications for tafamidis accepted for filing by FDA.NEWS18: US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy.NEWS19: Pfizer Says FDA Accepts Regulatory Submissions For Review Of Tafamidis.NEWS20: Pfizer Says FDA Accepts Regulatory Submissions For Review Of Tafamidis.NEWS21: Here Are the 2019 Dogs of the Dow.NEWS22: Here Are the 2019 Dogs of the Dow.NEWS23: Here Are the 2019 Dogs of the Dow.
2019-01-15: NEWS1: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS2: XLV, PFE, UNH, MRK: Large Inflows Detected at ETF.NEWS3: XLV, PFE, UNH, MRK: Large Inflows Detected at ETF.NEWS4: Bristol-Myers' Drug Combination Gets EU Nod for Renal Cancer.NEWS5: Bristol-Myers' Drug Combination Gets EU Nod for Renal Cancer.NEWS6: Pfizer Gets FDA's Priority Review for Rare Disease Candidate.NEWS7: Pfizer Gets FDA's Priority Review for Rare Disease Candidate.NEWS8: Health Care Sector Update for 01/15/2019: BPTH, ALNY, TRXC, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 01/15/2019: BPTH, ALNY, TRXC, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Bristol-Myers' Drug Combination Gets EU Nod for Renal Cancer.NEWS11: Why Amarin Is Soaring in First Half of January.NEWS12: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS13: Pfizer Gets FDA's Priority Review for Rare Disease Candidate.NEWS14: Why Amarin Stock Skyrocketed 239% in 2018 -- and Is Up 26% in 2019.NEWS15: Why Amarin Stock Skyrocketed 239% in 2018 -- and Is Up 26% in 2019.NEWS16: Here's How Pfizer Gained 20.5% in 2018.NEWS17: Here's How Pfizer Gained 20.5% in 2018.NEWS18: First Device For Congenital Heart Defect, AIMT & US Shutdown, ASLN On Watch.NEWS19: First Device For Congenital Heart Defect, AIMT & US Shutdown, ASLN On Watch.NEWS20: 8 Dividend Stocks With Growth on the Horizon.NEWS21: 8 Dividend Stocks With Growth on the Horizon.NEWS22: Here&apos;s How Pfizer Gained 20.5% in 2018.
2019-01-16: NEWS1: Court rules against Pfizer in religious discrimination suit.NEWS2: Why Ligand Pharmaceuticals Tanked 25%.NEWS3: 6 Top Gainers In Healthcare Sector (BIOC, ALRN, VCNX...).NEWS4: 6 Top Gainers In Healthcare Sector (BIOC, ALRN, VCNX...).NEWS5: Is Pfizer a Buy?.NEWS6: Is Pfizer a Buy?.NEWS7: Health Care Sector Update for 01/16/2019: APTX, KTOV, STML, JNJ, PFE, ABT, MRK, AMGN.NEWS8: Health Care Sector Update for 01/16/2019: APTX, KTOV, STML, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for January 17, 2019.NEWS10: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for January 17, 2019.NEWS11: Is Pfizer a Buy?.NEWS12: See what the IHS Markit Score report has to say about Pfizer Inc..NEWS13: Fiserv to buy First Data in $22B all-stock deal.NEWS14: Pfizer (PFE) Gains But Lags Market: What You Should Know.NEWS15: Pfizer (PFE) Gains But Lags Market: What You Should Know.
2019-01-17: NEWS1: The Stable Value Stock Is Built to Weather Market Storms.NEWS2: 3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group.NEWS3: 3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group.NEWS4: J&J (JNJ) to Commence Pharma Q4 Earnings: What to Expect.NEWS5: 3 Big Stock Charts for Thursday: Fiserv, Pfizer and PNC Financial Services Group.

Answer: Rise